Your cart is empty.
Männedorf, Switzerland, March 15, 2011 – The recently launched Gas Control Module (GCM™) for Tecan’s Infinite® 200 PRO offers researchers at the University of Salzburg a new approach to the investigation of cellular processes, by allowing incubation of cells within the reader for the first time. Priv-Doz Dr Kristjan Plaetzer from the Division of Physics and Biophysics explained: “Fluorescence- and luminescence-based techniques are widely used to follow the kinetics of cellular processes, but these investigations are generally limited by the need to transfer cultures between a CO2 incubator and the reader at regular intervals. The development of the GCM for the Infinite 200 PRO eliminates this obstacle to research, by allowing cultures to be incubated within the reader without affecting the resulting data.”
“We first began working with Tecan many years ago, and have always been very impressed by its instruments and services,” Kristjan continued. “The flexibility of the Infinite M200 PRO is a real advantage in a research environment. The Quad4 Monochromators™ system allows us to run a wide spectrum of assays without the need to buy new filter sets, and the dual injector module further increases the flexibility of the instrument, particularly for luminescence measurements. The latest version of the systems i-control™ software is also well suited to cell-based studies; you can easily set the incubation temperature and define the plate type, and it offers a large number of pre-defined parameters for specific assay kits. Overall, this makes the Infinite 200 PRO an ideal tool for process biology, in the same way the microscope is a tool for structural biology.”
To find out more on Tecan’s Infinite 200 PRO multimode readers, visit http://www.tecan.com/infinite200
For more information please contact
Tecan Trading AG
Tel +41 (0)44 922 81 11
Fax +41 (0)44 922 81 12
Tecan (www.tecan.com) is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics. The company specializes in the development, production and distribution of instruments and automated workflow solutions for laboratories in the life sciences sector. As an original equipment manufacturer, Tecan is also a leader in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both Europe and North America and maintains a sales and service network in 52 countries. In 2009, Tecan generated sales of CHF 392 million (USD 361.2 million; EUR 259.6 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TK: TECN/Reuters: TECZn.S/ ISIN CH0012100191).